Skip to main content
Premium Trial:

Request an Annual Quote

Cofactor Genomics Named Agilent CSP for NGS Target Enrichment

NEW YORK (GenomeWeb) – Cofactor Genomics today said that it has been named a certified service provider for Agilent's SureSelect Methyl-Seq target enrichment.

The St. Louis-based firm said that it has "built one of the most comprehensive methylation analysis services in the industry and is able to handle every piece of the project, from DNA extraction to analysis."

"One of the next logical steps in understanding genetic modulation by modification is to assess the methylation state of DNA," Cofactor Genomics CSO Jon Armstrong said in a statement. "We … look forward to providing ground-breaking results in the study of epigenetics with their products."

Last September Cofactor received a $300,000 grant from the National Heart, Lung, and Blood Institute and the National Human Genome Research Institute to identify sites of epigenetic modifications that contribute to cardiovascular disease endpoints.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.